about
Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation.Abdominal obesity is associated with peripheral artery disease in hemodialysis patients.Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease.Spatial heterogeneity in skeletal muscle microvascular blood flow distribution is increased in the metabolic syndromePrevalent peripheral arterial disease and inflammatory burden.High levels of serum β2-microglobulin predict severity of coronary artery diseaseAssociations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial diseasePeripheral artery disease, biomarkers, and darapladib.Genetics of peripheral artery diseaseOxidation-specific biomarkers and risk of peripheral artery diseasePlasma free H2S levels are elevated in patients with cardiovascular disease.Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.β-blockade: benefits beyond blood pressure reduction?Recent advances in proteomic technologies applied to cardiovascular disease.A compendium on peripheral arterial disease.Prognostic value of cardiovascular MR imaging biomarkers on outcome in peripheral arterial disease: a 6-year follow-up pilot study.Elevated serum osteoprotegerin may predict peripheral arterial disease after kidney transplantation: a single-center prospective cross-sectional study in Taiwan.Twenty-Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC).Translational Bioinformatics Approaches to Drug Development.β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients.Identification of protein biomarkers associated with cardiac ischemia by a proteomic approach.Comparison of protein-chip array analysis and traditional ELISAs for biomarker detection of diabetic limb arterial stenosis.Risk factors for peripheral artery disease among patients with diabetes in Saudi Arabia.
P2860
Q33754984-E56E7333-0DD5-42A0-A752-C73EAC0CA927Q34807672-4E5E53EC-74C3-488C-8E6E-83F48D3D79A9Q35232453-8F9C9532-13B0-4860-8518-B98E0398356EQ35396951-6F8B1D6B-AA86-48C1-A4FD-D70765AA59FDQ36219072-9F4B1633-2750-41CA-9BB0-883F4A4DEC43Q36294507-FAC8E77B-E5B1-4377-830B-D349710D95FEQ36764895-A420F2BA-A139-4D61-8D2B-71DC97BAB639Q37114477-3F84B31D-4A5E-4D86-9F36-3F3C64452DB7Q37127078-496EFC2A-E545-4813-B4C5-99D1B9AE2394Q37131142-B482A348-F4C2-40ED-8C3D-A4320A2DAFF3Q37328808-B8ED54C0-0891-4525-BAC5-0201CCE4D879Q37883007-EDFD26B0-8FD3-4F48-9681-26AEB2079381Q37978685-AB0D7C11-1C67-4F69-A662-8EE318CAC6E4Q38034137-6236B615-20E8-44E4-A9D1-8B3A24A12007Q39968344-49260D72-111E-4065-A384-3A103BE9B3E0Q40742857-5546B9D0-958C-425C-AB62-127A8BB7BDC1Q42278602-E32947EA-B075-4492-97B8-3A2E02948FF4Q42373691-B3B6C680-3ADB-4865-A913-8D237F788E33Q42922307-565E970B-C535-45BC-8E40-2D87A578FACBQ44285321-9BD92C51-99EC-4D32-A3AE-C603A4A312A5Q44801273-8CF12CCD-1AA3-4263-9C54-301CED57988EQ51277470-BFC71FB0-B7BA-4D32-A167-F3BB9F2B9BD6Q51325762-4B8F0414-CA6B-407A-A0A7-F2CB7A8AE293
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Biomarkers of peripheral arterial disease.
@ast
Biomarkers of peripheral arterial disease.
@en
type
label
Biomarkers of peripheral arterial disease.
@ast
Biomarkers of peripheral arterial disease.
@en
prefLabel
Biomarkers of peripheral arterial disease.
@ast
Biomarkers of peripheral arterial disease.
@en
P2860
P1476
Biomarkers of peripheral arterial disease
@en
P2093
Andrew M Wilson
P2860
P304
P356
10.1016/J.JACC.2009.08.090
P407
P577
2010-05-01T00:00:00Z